ABSTRACT Neisseria meningitidis colonizes the nasopharyngeal mucosa of healthy populations asymptomatically, although the bacterial surface is rich in motifs that activate the host innate immunity. What determines the tolerant host response to this bacterium in asymptomatic carriers is poorly understood. We demonstrated that the conserved meningococcal surface protein NhhA orchestrates monocyte (Mo) differentiation specifically into macrophage-like cells with a CD200R hi phenotype (NhhA-M). In response to meningococcal stimulation, NhhA-M failed to produce proinflammatory mediators. Instead, they upregulated interleukin-10 (IL-10) and Th2/regulatory T cell (Treg)-attracting chemokines, such as CCL17, CCL18, and CCL22. Moreover, NhhA-M were highly efficient in eliminating bacteria. The in vivo validity of these findings was corroborated using a murine model challenged with N. meningitidis systematically or intranasally. The NhhA-modulated immune response protected mice from septic shock; Mo/M depletion abolished this protective effect. Intranasal administration of NhhA induced an antiinflammatory response, which was associated with N. meningitidis persistence at the nasopharynx. In vitro studies demonstrated that NhhA-triggered Mo differentiation occurred upon engaged Toll-like receptor 1 (TLR1)/TLR2 signaling and extracellular signal-regulated kinase (ERK) and Jun N-terminal protein kinase (JNK) activation and required endogenously produced IL-10 and tumor necrosis factor alpha (TNF-␣). Our findings reveal a strategy that might be adopted by N. meningitidis to maintain asymptomatic nasopharyngeal colonization. 
he Gram-negative bacterium Neisseria meningitidis is the leading cause of bacterial meningitis and septicemia. Despite the relatively low incidence rates of the disease, meningococci are obligate commensals in humans and are present in the upper respiratory tract of approximately 10% of healthy individuals asymptomatically (1) . The rates of meningococcal carriage are even higher during the teenage years and early adulthood (2) and among semiclosed populations (3) . A variety of surface components on meningococci, such as endotoxin lipooligosaccharide (LOS), are potent proinflammatory factors that can activate the host innate immune response (4) (5) (6) ; the strategies used by this bacterium to limit local inflammation and establish the carriage status remain unclear.
Monocytes (Mo) represent a large pool of circulating precursors that can differentiate into macrophages (M) and migrating dendritic cells (DCs) and thereby perform important regulatory functions in innate and adaptive immunity (7) . Furthermore, the Mo-derived M exhibit a substantial heterogeneity of phenotypes whose immunomodulatory properties in host defense are dictated by the external inflammatory milieu (8) . Classically activated M (referred to as M1M) polarized in response to Th1 cytokines (e.g., gamma interferon [IFN-␥]) are characterized by the production of proinflammatory mediators and cytotoxic effector molecules such as nitric oxide (NO) and reactive oxygen intermediates. Thus, M1M play a dominant role in controlling acute infectious diseases but have the potential to cause tissue damage and septic shock upon aberrant activation. In contrast, Th2 cytokines (e.g., interleukin-4 [IL-4] and IL-13) polarize M toward an alterna-tively activated phenotype (also known as M2M); these cells produce large amounts of anti-inflammatory mediators and play an important role in counteracting harmful inflammatory responses. In addition, increased expression of arginases (Arg) by M2M is associated with tissue healing. It has been observed that M2M may generate a survival niche that contributes to chronic infections induced by pathogens such as Salmonella enterica serovar Typhimurium (9) , Mycobacterium tuberculosis (10) , and Helicobacter pylori (11) . Cytokines endogenously produced by host cells upon activation by microbial components play an essential role in orchestrating the dynamic programming of M. Although both LOS and non-LOS surface components on N. meningitidis have been demonstrated to be able to target monocytes and trigger cytokine production (6, 12) , whether N. meningitidis can modulate the functional polarization of M and its impact on bacterial carriage remains unclear.
Neisseria Hia/Hsf homologue A (NhhA) belongs to the family of trimeric autotransporter adhesins and is a conserved surface protein in a number of disease-associated N. meningitidis strains (13) . Therefore, NhhA has been considered to be a potential vaccine candidate (14) . NhhA plays a variety of roles in promoting bacterial survival, including mediating bacterial interaction with epithelial cells (15) and enhancing bacterial complement resistance via binding to activated vitronectin (16) . Our previous studies demonstrated the immunostimulatory properties of NhhA on M (5), which led us to examine its effect on Mo activation and functional differentiation. In this study, we identified a novel function of NhhA in programing Mo differentiation toward M with a CD200R hi immune homeostatic phenotype (NhhA-M). In vitro and in vivo studies revealed that NhhA-M alleviated inflammatory response upon meningococcal stimulation, which was associated with enhanced bacterial colonization. Overall, modulating M polarization may represent a previously undescribed strategy though which N. meningitidis potentiates host immune tolerance and ensures asymptomatic bacterial carriage at the nasopharyngeal mucosa.
RESULTS
NhhA skews monocyte differentiation toward macrophages but not dendritic cells. Previously, we observed that NhhA induces the production of cytokines in M (5), which led us to examine its effect on the activation and functional differentiation of monocytes. We found that NhhA is able to induce substantial amounts of inflammatory mediators in human peripheral monocytes in a dose-dependent manner (data not shown). Furthermore, we noticed morphological changes in Mo following NhhA treatmentthe cells were clustered, with enhanced adhesion and increased cytoplasmic granularity (Fig. 1A and data not shown). The differentiating action of NhhA was both time and dose dependent, with the strongest effect observed when Mo were treated with NhhA (50 nM) for 3 days (data not shown). In contrast, NhhA subjected to heat treatment failed to induce Mo differentiation (data not shown), ruling out the possibility that the observed effect of NhhA was caused by lipopolysaccharide (LPS) contamination. Prolonged NhhA treatment (5 to 7 days), at a concentration of 50 nM, did not enhance cell maturation but led to increased amounts of dead cells, as observed by dual staining of annexin V (data not shown), likely because of its apoptotic effect on M (17) . Based on these observations, NhhA (50 nM) and a 3-day incubation period were subsequently used to induce monocyte differentiation, unless otherwise specified.
Flow cytometric analysis showed that the expression of membrane CD14, but not CD1a (a surrogate marker for DCs), was highly induced on NhhA-differentiated cells (Fig. 1B and C) , suggesting an M-like phenotype. To ascertain the endogenous effect of NhhA on Mo-M differentiation, we stimulated Mo with the FAM20 wild-type (WT) strain or an isogenic NhhA-deficient mutant (⌬NhhA) strain. We found that the lack of NhhA significantly attenuated the differentiating effect of the bacteria, as assessed by morphology, intracellular granularity, and attachment (data not shown). At the same time, decreased amounts of CD14 hi cells (44.6% Ϯ 5.4% versus 23.4% Ϯ 3.7%, P ϭ 0.007) were observed ( Fig. 1D and E) . Intriguingly, the expression of CD1a was not affected (Fig. 1D) , suggesting that neither the WT nor the ⌬NhhA strain stimulated the conversion of Mo to DCs. Together, these data demonstrated a novel immunomodulatory role for NhhA in skewing the differentiation of Mo specifically toward M.
The differentiating effect of NhhA requires the full passenger domain. The passenger domain of NhhA consists of three regions, in which the middle region, with two conserved modules, contains the binding site for heparan sulfate (18) . To map the functional region of NhhA that triggers Mo differentiation, we generated various forms of NhhA resembling the N-terminal, middle, and C-terminal regions of the passenger domain under native conditions and evaluated their potential to trigger differentiation. In contrast to NhhA-FL, the recombinant NhhA containing a fulllength passenger domain (5), truncated NhhA proteins could neither bind cells (see Fig. S1A , upper panel, in the supplemental material) nor trigger Mo-M differentiation, as determined by measuring side scatter (SSC) and CD14 expression of cells (see Fig. S1A , lower panel). NhhA trimerization (13) was detected by native polyacrylamide gel electrophoresis (see Fig. S1B ), indicating a link between the structural organization of NhhA and its biological activity.
NhhA-triggered M differentiation relies on TLR1/TLR2 activation. Blocking cell endocytosis with cytochalasin D, a drug that inhibits actin polymerization, had no effect on differentiation, as assessed by measuring CD14 expression and SSC ( Fig. 2A) , suggesting that the NhhA-triggered M differentiation was mediated by cell surface receptors. Surface Toll-like receptors (TLRs) play a crucial role in sensing microbial stimulation and triggering Mo differentiation (19) . By using specific inhibitory antibodies to human TLRs, we found that blocking the activation of either TLR1 or TLR2 could significantly inhibit the action of NhhA. No effect on differentiation could be detected when TLR6 or TLR4 signaling was blocked, although inhibition of TLR4 partially attenuated NhhA-induced CD14 expression ( Fig. 2A) . Scavenger receptors of Mo/M recognize various surface molecules on N. meningitidis (20) and mediate the nonopsonic uptake of bacteria, whereas heparan sulfate has been demonstrated to interact with NhhA in vitro (21) . Nevertheless, Mo pretreated with dextran sulfate (DxSO 4 , a broad-range antagonist ligand of scavenger receptors) or heparinase III differentiated to a degree similar to that observed for control cells ( Fig. 2A) , suggesting that none of these factors plays an essential role in NhhA-triggered differentiation. These results indicate that the differentiating effect of NhhA is initiated through TLR1/TLR2 activation.
Recognition by heterodimers of TLR1 and TLR2 activates the nuclear factor NF-B, mitogen-activated protein kinase (MAPK), and phosphoinositide 3-kinase (PI3K)/Akt signaling pathways, which coordinately regulate differentiation-and inflammationassociated gene activities (19) . Western blot analysis revealed rapid phosphorylation of Akt, extracellular signal-regulated kinases (ERKs), c-Jun N-terminal protein kinases (JNKs), and p38 in Mo 10 to 60 min after stimulation with NhhA (Fig. 2B) . Blocking TLR1 or TLR2 signaling selectively reduced NhhA-triggered ERK and JNK phosphorylation, whereas Akt and p38 activations were not affected (Fig. 2C) , indicating that another NhhA-sensing receptor(s) is involved in activating these signaling cascades. We further verified the involvement of the ERK and JNK signaling pathways in NhhA-triggered Mo differentiation by treating the cells with specific inhibitors for ERK (PD98059) and JNK (SP600125), respectively (see Fig. S2 in the supplemental material). Moreover, inhibition of NF-B, but not activator protein 1 (AP-1) activity, eliminated the differentiating effects of NhhA (see Fig. S2 ).
Together, these data demonstrate a coordinating role for TLR1/TLR2-activated ERK/JNK MAPK and NF-B signaling in M differentiation triggered by NhhA.
NhhA-induced M differentiation is dependent on endogenously produced IL-10 and TNF-␣. TLR1/2-mediated NF-B activation regulates the inducible expression of a broad array of inflammatory mediators that promote M differentiation (19, 22) . To identify the factors underlying the differentiating effect of NhhA, we studied the transcriptional profile of a variety of genes coding for cytokines and growth factors in Mo upon NhhA stimulation by quantitative real-time PCR (qPCR) and searched for factors whose production was specifically TLR1/2 or NF-B pathway dependent. We found that NhhA stimulation had no effect on the transcription of IL-4, IL-13, transforming growth factor ␤ (TGF-␤), IFN-␥, IL-15, macrophage colony-stimulating factor (M-CSF), or granulocyte-macrophage CSF (GM-CSF) (Fig. 3A and data not shown). In contrast, the transcription of IL-6, IL12b, IL-10, tumor necrosis factor alpha (TNF-␣), and IL-32 was markedly upregulated by NhhA (Fig. 3A) . Furthermore, a blocking assay revealed that the induction of IL-6, IL-12b, IL-10, and TNF-␣ mRNA was dependent on TLR1/TLR2 or NF-B signaling (Fig. 3A) . To demonstrate the specific effect of the applied blocking antibodies, we treated cells with the isotype-matched control antibody and found that NhhA retained the capacity to induce IL-6 and TNF-␣ (data not shown). Furthermore, some cells treated with TLR-blocking antibodies were also stimulated with their specific agonists, such as PAM 3 CSK 4 , peptidoglycan, and LPS. Under this condition, cytokine production in both Mo and M was specifically blocked (data not shown).
To identify the mediators that play essential roles in NhhAtriggered Mo differentiation, we stimulated Mo with NhhA in the presence of neutralizing antibodies or inhibitors directed against the indicated cytokines. As shown in Fig. 3B , neutralizing IL-6 or IL-12b had no effects on cell differentiation. In contrast, neutralizing IL-10 or TNF-␣ diminished NhhA-induced Mo differentiation by 80% or 60%, respectively, as assessed by measuring cell granularity. Furthermore, neutralization of TNF-␣ reduced the expression of CD14, a coreceptor for detecting LPS, on NhhAtreated cells by nearly 50%. Consistent with the observation that NhhA has no effect on IL-15 and M-CSF transcription (Fig. 3A) , blocking IL-15 or M-CSF signaling did not impair NhhA-induced differentiation (Fig. 3B) . Moreover, inhibition of IL-32 activation did not show any effect on NhhA-mediated cell differentiation (Fig. 3B) . These results provide evidence that NhhA programs M differentiation upon TLR1/TLR2 activation in an IL-10/TNF-␣-dependent manner.
NhhA induces CD200R expression on macrophages. Next, we characterized the phenotype of NhhA-derived M (NhhA-M) by flow cytometry. Expression levels of proinflammatory cytokine-associated parameters, including molecules that support antigen presentation (HLA-DR, CD86, and CD80) or sense bacterial infection (TLR4), were low in NhhA-M (Fig. 4 and data not shown). In contrast, expression of the mannose receptor CD206 and CD200R, a negative regulator of M activation, was significantly upregulated in these cells (Fig. 4) .
NhhA-M are hyporesponsive to meningococcal stimulation but are competent at eliminating bacteria. We confirmed the upregulation of CD200R in NhhA-M (Fig. 4) . Therefore, we analyzed the profile of inflammatory mediators generated by these cells upon meningococcal stimulation by qPCR ( Fig. 5A and data not shown). NhhA-M were inert to meningococcal stimulation, which impeded the induction of proinflammatory cytokines (IL-6, TNF-␣, IL-12, IL-23, and IL-1␤) compared with Mo. In contrast, transcription levels of anti-inflammatory cytokines (IL-10 and IL-4) were not affected, and a transient upregulation on the first day after NhhA treatment was detected. Moreover, T regulatory cell (Treg)-or Th2-recruiting chemokines (CCL18, CCL17, and CCL22) were consistently upregulated in NhhA-M upon bacterial infection. The trend of cytokine production could be detected in M differentiated by NhhA for up to 5 days, indi- cating that the observed phenotype is not a consequence of insufficient maturation or differentiation status.
The intrinsic action of NhhA on the functional polarization of M was confirmed by infecting Mo with WT or ⌬NhhA meningococci. As shown in Fig. S3 in the supplemental material, WT bacteria containing NhhA triggered the transcription of IL-10 and, to a greater extent, inducible nitric oxide synthase (iNOS), whereas ⌬NhhA bacteria more efficiently induced IL-12b.
We further studied the potential of NhhA-M to take up and eliminate bacteria by flow cytometry and a gentamicin protection assay, respectively. We found that NhhA-M could engulf and kill bacteria at a level comparable to that observed for M1M, which was significantly higher than that of M2M and DCs (Fig. 5B to  D) . Taken together, these data indicate that NhhA-M resist N. meningitidis stimulation but exhibit an augmented capacity to eliminate bacteria.
NhhA modulates phenotype polarization of macrophages in vivo. To elucidate the in vivo effect of NhhA on M polarization and its impact on host responses to meningococcal infection, a CD46 ϩ/ϩ transgenic mouse model of meningococcal infection was applied. The immune responses observed in this mouse model may be of particular interest with respect to human pathogens because CD46, a ubiquitously expressed type I transmembrane glycoprotein in humans, is not only a regulator of complement activation but is also engaged in cytokine production (23) . We challenged mice intraperitoneally (i.p.) with NhhA (50 nM) for 3 days and found that this treatment did not affect the total number of peritoneal cells (Fig. 6A ) or peritoneal M (Fig. 6B ) compared with control mice. Upon meningococcal infection (i.p. with 10 8 CFU of FAM20 per mouse), the number of peritoneal cells was dramatically increased in NhhA-treated mice, indicating a rapid influx of immune cells (Fig. 6A) . The increase in the number of peritoneal cells may be primarily attributed to infiltrating M (F4/80 hi CD11b hi Ly6C int Ly6G Ϫ [Fig. 6B] ). In contrast, the numbers of peritoneal neutrophils (Ly6G ϩ F4/80 Ϫ CD11b ϩ Ly6C int ), DCs (CD205 ϩ CD19 Ϫ CD3 Ϫ ), T cells (CD3 ϩ CD19 Ϫ ), or B cells (CD19 ϩ CD3 Ϫ ) were not markedly different (see Fig. S4 in the supplemental material). Although we could not rule out the possibility that NhhA might polarize the functional phenotype of . RNA was extracted after 3 h, and the mRNA levels of the indicated cytokines were quantified by real-time PCR (qPCR). The data were normalized to the reference gene rpl37A and are presented as fold change relative to that of Mo without NhhA stimulation, which was set to 1. Data shown are the mean Ϯ standard deviation from three independent experiments; *, P Ͻ 0.05 compared with the control using ANOVA followed by the Bonferroni post hoc test. (B) Mo were stimulated with 50 nM NhhA alone (control) or in the presence of the blocking agent for the indicated cytokines as described in Materials and Methods. The differentiation state was assessed by the flow cytometric analysis of CD14 expression and SSC parameters (shown as median fluorescence intensity [MFI]). Error bars indicate medians with interquartile ranges of three independent experiments. Data are presented as fold change relative to control; *, P Ͻ 0.05 compared with the control using ANOVA followed by the Bonferroni post hoc test.
other immune cells, our data do support the role of NhhA in targeting Mo-M differentiation in vivo. Peritoneal M were isolated for phenotypic and functional analyses. In contrast to cells collected from control mice, M from NhhA-treated mice expressed significantly higher levels of CD206 and Arg-1 mRNA (Fig. 6C , P Ͻ 0.05), indicating an M2 M-like phenotype. Indeed, these cells exhibited a decreased potential to generate proinflammatory cytokines such as IL-6 and TNF-␣ (Fig. 6D ) upon meningococcal stimulation. Furthermore, they displayed a marked capacity to engulf and kill the internalized bacteria ( Fig. 6E and F) , which is consistent with our in vitro findings.
The intrinsic effect of NhhA on immunomodulation of M in vivo was further tested by infecting CD46 ϩ/ϩ mice i.p. with WT or ⌬NhhA meningococcal bacteria (10 8 CFU/mouse, for 12 h), and peritoneal cells were analyzed by flow cytometry. The absence of NhhA in meningococci did not affect the Mo (F4/80 med CD11b med ) population in the peritoneal cavity (23.6% Ϯ 1.8% versus 25.4% Ϯ 4.7%, P ϭ 0.59). However, a significantly larger amount of M (F4/80 hi CD11b hi ) was detected in the peritoneal cavity of mice challenged with the WT strain compared with the ⌬NhhA bacteria (30.6% Ϯ 4.0% versus 16.7% Ϯ 3.3%, P ϭ 0.005) (Fig. 7A) . Real-time PCR and enzyme-linked immunosorbent assay (ELISA) studies revealed that peritoneal M in response to ⌬NhhA bacteria produced more proinflammatory cytokine IL12b but smaller amounts of anti-inflammatory cytokine IL-10 (Fig. 7B) . The bactericidal mediator iNOS was diminished in the ⌬NhhA bacterium-treated cells. Consistently, lower nitrite levels in the peritoneal cavity were detected in the ⌬NhhA bacteriumtreated mice than in the mice stimulated with the WT meningococci (Fig. 7C) . These results were in line with our in vitro observations (see Fig. S3 in the supplemental material) and clearly demonstrated the intrinsic role of NhhA in modulating M differentiation in vivo.
NhhA-M prevent bacterial dissemination in an experimental meningococcal infection model. The data reported above suggested that NhhA-programmed M might dampen the immune response to meningococcal stimulation. To test this hypothesis, CD46 ϩ/ϩ transgenic mice pretreated with NhhA were challenged with FAM20 (i.p.), and the development of septic shock was monitored and compared with that of control mice. As shown in Fig. 8A , NhhA pretreatment resulted in complete survival compared with control mice (100% versus 20%) 3 days postinfection. Bacteremia levels were significantly lower in the NhhA-treated mice than in the control group even as early as 2 h postinfection, and no bacteria could be detected 24 h postinfection (Fig. 8B) . Bacterial survival levels in whole blood collected from control and NhhA-pretreated mice were comparable, indicating that bacterial elimination occurred mainly in the peritoneal cavity (see Fig. S5A in the supplemental material). Furthermore, NhhA treatment alleviated the host proinflammatory immune responses, as indicated by significantly decreased levels of IL-6 and TNF-␣, but comparable levels of IL-10 in both the blood (Fig. 8C ) and peritoneal cavity (see Fig. S5B ), compared with the control mice.
To confirm the role of NhhA-modulated M polarization in the host immune response to meningococcal infection, we performed the in vivo experiments under Mo/M-deficient conditions generated by pretreating mice with clodronate-containing liposomes. We found that the NhhA-triggered protection was abolished, as assessed by survival curves (Fig. 8A ) and bacteremia levels (Fig. 8B ). These data demonstrate that NhhA targets the functional programming of M to dampen proinflammatory responses and occlude bacterial dissemination in vivo.
NhhA potentiates nasopharyngeal persistence of N. meningitidis. To determine whether NhhA modulates mucosal defense against N. meningitidis at the nasopharynx, a natural niche of meningococci, we pretreated CD46 ϩ/ϩ transgenic mice with NhhA (50 nM) before challenging them with meningococci through an intranasal (i.n.) route. Bacterial burden and cytokine levels in the nasal lavage fluid collected from mice at 12 h postinfection were analyzed. Mice pretreated with NhhA harbored more bacteria at the nasopharynx than did control mice (Fig. 9A) . Surprisingly, we observed a sharp reduction in IL-6 levels in these mice compared with those observed in the control group. On the other hand, IL-10 levels were comparable between the two groups (Fig. 9B) . The enhanced levels of proinflammatory cytokines may contribute to tissue injury. Therefore, we hypothesized that the nasopha- ryngeal mucosa of mice pretreated with NhhA would display a lower inflammatory response upon meningococcal infection, whereas the control mice would display a greater inflammatory response, although the bacterial level was diminished in the control mice. Our hypothesis was confirmed by histological studies: the nasopharyngeal mucosa of NhhA-treated mice showed less leukocyte infiltration and enhanced mucosal integrity features that were not observed in the control mice (Fig. 9C) . We tried different antibodies to stain M in the nasopharyngeal mucosa of mice; however, we could not obtain satisfactory images. The agents used for decalcification and embedding during tissue preparation may influence the immunohistochemical detection of specific markers.
DISCUSSION
Two long-standing mysteries are why many healthy individuals are asymptomatic carriers of N. meningitidis and how meningococci colonize nasopharyngeal mucosa without activating the host innate immune response. Here, we provide evidence that the highly conserved meningococcal surface protein NhhA has a profound effect on modulating the host immune response through programming M polarization toward an immune homeostatic phenotype, named NhhA-M. These M have an enhanced capacity to clear invading bacteria. More importantly, they are hyporesponsive to meningococcal stimulation, likely through CD200R-triggered anti-inflammatory signaling in immune cells (24) . Together, all of these influences may favor bacterial commensal colonization at the nasopharyngeal mucosa. The ability of NhhA to modulate M polarization was further confirmed in vivo using a murine system. We used both the peritoneal and intranasal routes to study the effect of NhhA-mediated immune modulation on meningococcal intravascular dissemination and colonization, respectively. When the mice were challenged peritoneally, NhhA pretreatment induced significantly decreased levels of not only proinflammatory cytokines but also invading bacteria in the blood, which were associated with enhanced survival compared with that observed for the control group. When an intranasal route of challenge was applied, the NhhA-induced hyporesponsiveness to meningococcal stimulation was also detected in the nasopharyngeal mucosa, which was Normalized data, shown as the mean Ϯ standard deviation from three independent experiments, are presented as fold change compared with uninfected Mo (day 0). *, P Ͻ 0.05 compared with control at day 0 using ANOVA followed by the Bonferroni post hoc test. (B and C) NhhA-M, M1M, M2M, or DCs, generated as described in Materials and Methods, were challenged with fluorescein isothiocyanate (FITC)-labeled N. meningitidis FAM20 (MOI, 100) for 40 min at 37°C. The intracellular fluorescence intensity was determined by flow cytometry, and a representative plot is shown in panel B. Quantitative data for median fluorescence intensity (MFI), shown as medians with interquartile ranges from three independent experiments, are presented in panel C. *, P Ͻ 0.05 using ANOVA followed by the Bonferroni post hoc test. (D) NhhA-M, M1M, M2M, or DCs, generated as described for panel B, were challenged with live FAM20 (MOI, 100) for 40 min. After intensive washing and antibiotic treatment to kill extracellular bacteria, survival of intracellular bacteria was determined by a modified gentamicin protection assay, as described in Materials and Methods. The data represent the mean Ϯ standard deviation from three independent experiments. *, P Ͻ 0.05 using ANOVA followed by the Bonferroni post hoc test. NS, not significant. associated with enhanced bacterial colonization. Thus, the conserved meningococcal surface protein NhhA plays a key role in inducing host immune homeostasis at the mucosal surface and contributes bacterial asymptomatic colonization. As a corroborative example, previous studies by Krysko et al. have shown that chronic rhinosinusitis characterized with M2 polarization of M is associated with enhanced colonization by Staphylococcus aureus in the nasal mucosa (25) . A recent study demonstrated that meningococcal LOS, via TLR4, augments CD200 expression on M (26) . Meningococcal infection at the nasopharyngeal mucosa is a dynamic process, including adhesion and invasion of bacterial cells (15) , tissue damage (27) , and shedding of bacterial outer membrane vesicles (28) , as well as influx of immune cells to the infection site (15, 29) . It is therefore reasonable to speculate that N. meningitidis may interact with and modulate the functional polarization of M or even other immune cells through distinct mechanisms and skew the host mucosal immune response, thereby favoring asymptomatic colonization of the host by the bacterium.
A novel finding of this study is that meningococci block the differentiation of Mo into DCs; a similar effect has been observed for a range of chronic-infection-associated pathogens such as M. tuberculosis (30) and Salmonella Typhimurium (30, 31) . Inhibition of Mo-DC differentiation and the generation of antiinflammatory M may decrease the chances of meningococcal dissemination, which could in turn diminish the overactivation of local inflammatory responses and hence facilitate bacterial containment at the nasopharyngeal mucosa. Our finding that NhhA-M exhibit high potential to eliminate the bacteria corroborates this idea. NhhA expression is conserved in nearly all analyzed meningococcal isolates (13) , suggesting that the functions of NhhA are likely comparable throughout the species. NhhA exhibits a certain sequence variation between different species; further studies are necessary to determine whether NhhA has a strainspecific role.
NhhA-M exhibited efficient phagocytosis coupled with attenuated induction of proinflammatory cytokines upon meningococcal stimulation, a character that is in sharp contrast to the M2M triggered by the Th2 cytokine IL-4 (32). Our results revealed that NhhA, in contrast to IL-4, induces rapid activation of the Akt/PI3K signaling pathway that is associated with macropinocytic uptake by M (33), suggesting that differential signaling activation by NhhA may be the underlying mechanism. A recent study by Frodermann et al. (34) further revealed the role of the activation of the PI3K pathway in inducing the IL-10 response in M upon TLR2 activation by staphylococcal peptidoglycan. We also observed that NhhA-stimulated M induced IL-10 expression in a PI3K-dependent manner (data not shown). However, the NhhA-triggered Akt/PI3K activation was dispensable for Mo differentiation and was uncoupled from TLR1/TLR2 signaling, suggesting that an additional receptor(s) is involved in sensing NhhA and activating this signaling pathway.
Although NhhA-triggered monocyte differentiation is dependent on the activation of TLR1/TLR2 signaling, the results of this study suggest a unique role for endogenously produced IL-10 and TNF-␣ in Mo differentiation and M polarization upon NhhA stimulation. This role is mechanistically different from that of the TLR1/2 agonist PAM 3 CSK 4 , in which endogenously produced IL-15 and GM-CSF initiate Mo-M and Mo-DC differentiation, respectively (19) . Previous studies have shown that TNF-␣ trig- Some peritoneal M were treated with live FAM20 (MOI, 100) for 40 min, and bacterial elimination was determined as described in Fig. 5D . Data are presented as the mean Ϯ standard deviation (n ϭ 3 or 4). *, P Ͻ 0.05 compared with the control group using paired Student's t test. Data shown in panels A to F are representative of at least three independent experiments.
gers Mo differentiation by impeding the internalization of the M-CSF receptor (35) , whereas IL-10 augments monocyte differentiation (36) and Fc receptor-mediated phagocytosis (37) . A recent study by Nguyen et al. (38) demonstrated the in vivo role of IL-10 in M functional polarization; peritoneal administration of IL-10 induced M polarization toward a low-level major histocompatibility complex class II (MHC-II lo ) phenotype. These cells were defective in antigen presentation, but they exhibited extensive phagocytosis capacity (38) , which is in line with our observations. Indeed, both commensal microbiota and pathogens, such as group B Streptococcus (39), Staphylococcus aureus (34), and Bordetella bronchiseptica (40) , have been shown to be able to modulate IL-10 production in immune cells, which benefits bacterial colonization. Enhancing epithelial homeostasis (41, 42) and/or inducing a Treg response (43, 44) might be the underlying mechanism. Nevertheless, it would be worthwhile to further elucidate the role of IL-10 and IL-10-producing cells in the context of meningococcal colonization or even bacterial survival. IL-32 can trigger monocyte differentiation into either CD14 ϩ M-like (45) or CD1b ϩ DC-like cells (46) ; therefore, we investigated the possible role of IL-32 in NhhA-induced Mo differentiation. Although transcription of il-32 was highly induced, an in vitro blocking assay revealed that NhhA-triggered Mo-M differentiation was independent of IL-32. Nevertheless, we could not exclude the possibility that IL-32 might be involved in polarizing the M phenotype because it has been shown that IL-32 triggers M differentiation with both the M1 and M2 phenotypes (47) . Moreover, IL-10, generated upon NhhA stimulation, may block the formation of DC-like cells (22) .
Understanding the role of protein components in the programming of antigen-presenting cells is important considering that many of these factors are potential vaccine candidates against meningococcal disease. NhhA-triggered M exhibit a profound capacity to produce mediators that play key roles in priming and polarizing adaptive immune responses, such as CCL17, CCL18, and CCL22. The antigenic character of NhhA has been demonstrated in a mouse model (14) , and our findings further indicate its adjuvant activity. A recent study has demonstrated that targeting the reprogramming of antigen-presenting cells to induce immune tolerance is a persistence strategy for H. pylori (48) . Thus, the identification of surface receptors and signaling networks exploited by NhhA may provide a foundation for understanding vaccine-induced protective immunity against N. meningitidis. It is conceivable that the mucosal hyporeaction induced by NhhA-M can also be harnessed to prevent various mucosal inflammatory disorders.
In conclusion, our data provide novel insights into the complex actions of bacterial components in modulating the host immune responses. We reveal the molecular mechanisms that N. meningitidis might employ to avoid activating the host's in- flammatory response, thereby generating an immune homeostatic microenvironment compatible with commensal persistence of the bacterium.
MATERIALS AND METHODS
Bacteria. The N. meningitidis serogroup C strain FAM20 and the NhhAdeletion mutant (⌬NhhA) strain generated previously (5) were cultured on gonococcal (GC) agar (Acumedia, MI) supplemented with Kellogg's solution. To prepare fluorescein isothiocyanate (FITC)-labeled bacteria, FAM20 cells were harvested and incubated in FITC (0.1 mg/ml)-NaHCO 3 (0.1 M) buffer (pH 9.0) for 60 min at 25°C followed by intensive washing with phosphate-buffered saline (PBS). Recombinant NhhA proteins. The full-length passenger region of NhhA (NhhA-FL, amino acids [aa] 51 to 510) was generated in a previous study (5) . The N-terminal (NhhA-N, aa 50 to 164), C-terminal (NhhA-C, aa 380 to 510), and middle (NhhA-M, aa 164 to 380) regions of the NhhA passenger domain were amplified with the primer pairs listed in Table S2 in the supplemental material. After purification and digestion, the PCR products were cloned into a pET-21a expression vector. Expressed proteins were purified under native conditions (5) .
NhhA was routinely pretreated with the LPS antagonist polymyxin B (PMB), over the course of the entire study, although we observed that PMB omission did not affect the differentiating effect of the protein.
Monocyte isolation and differentiation. Human CD14 ϩ primary Mo were isolated from freshly prepared buffy coat (Karolinska Institutet Biobank, Stockholm, Sweden) using a pluriBead cell separation kit (pluriSelect GmbH, Leipzig, Germany). Mo were cultured in RPMI 1640 medium containing 10% fetal calf serum (FCS) in six-well culture plates at a density of 1 ϫ 10 6 /ml and exposed to NhhA, as indicated, to induce differentiation. Control cells were primed with M-CSF (50 ng/ml) for 5 days. A subset of these cells was then polarized for 24 h by either IFN-␥ (10 ng/ml) or LPS (20 ng/ml; Sigma-Aldrich, St. Louis, MO) to M1M or IL-4 (20 ng/ ml) to M2M. To generate DCs, Mo were cultured in GM-CSF (50 ng/ml) and IL-4 (20 ng/ml) for 5 days followed by LPS (20 ng/ml) for 2 days to enhance maturation. M-CSF and GM-CSF were purchased from ProSpec- Tany were purchased from InvivoGen (San Diego, CA) and tested for cytotoxicity using trypan blue and propidium iodide (PI) exclusion assays. Only inhibitor concentrations that ensured viability above 90% were used; control cells were treated with appropriate vehicles for the inhibitors.
Neutralization assays. To inhibit the function of surface receptors, cells were pretreated with dextran sulfate (100 g/ml), heparinase III (5 U/ml), or neutralizing antibodies (5 g/ml) directed against human TLR1, TLR2, TLR4, and TLR6 (InvivoGen) for 30 min. To suppress the biological activity of the cytokines, 10 g/ml of antibody-neutralizing IL-6, IL-12p40, or TNF-␣ (BioLegend, San Diego, CA) or IL-15 (R&D Systems, Minneapolis, MN) was added. Generation of IL-32 was blocked by treating cells with ␣-1 antitrypsin (0.5 mg/ml; Sigma-Aldrich) (49) . M-CSF receptor (M-CSFR) was blocked using GW2580 (10 M; Abcam, Cambridge, United Kingdom) to stop M-CSF signaling. Control cells were treated with an isotype-matched antibody or an appropriate vehicle.
Mouse model of infection and sampling. Experiments were performed with gender-matched 6-to 8-week-old hCD46Ge (CD46 ϩ/ϩ ) transgenic mice (50) . For the i.p. infection model, each mouse was pretreated i.p. once with 50 nM native or heat-inactivated (30 min at 95°C) NhhA (0.5 g NhhA per mouse with 0.2 ml of peritoneal fluid volume) for 1 to 3 days and then challenged with FAM20 (10 8 CFU). Preliminary experiments showed that NhhA treatments for 1 day and for 3 days yielded comparable results. Data from the 3-day treatment were presented to match conditions used in in vitro studies. In some experiments, mice were infected i.p. with wild-type (WT) or NhhA-deficient (⌬NhhA) FAM20 meningococcal strains (10 8 CFU) for 12 h. For the intranasal (i.n.) infection model, each mouse was pretreated intranasally twice with 50 nM native or heat-inactivated NhhA (0.03 g NhhA in 10 l of instillation volume) prior to bacterial challenge on day 3. Pretreatment with NhhA did not induce proinflammatory responses, as assessed by measuring the levels of IL-6 and TNF-␣ in either the blood or peritoneal fluid. In some experiments, mice were treated with clodronate-containing liposomes (200 l i.p.) 4 days before the procedure to delete Mo/M, and successful depletion (Ͼ95%) was confirmed by monitoring blood smears stained with Wright-Giemsa solution (Sigma-Aldrich).
The health status of the mice was closely monitored for 7 days, and blood samples (5 l) were collected from the tail vein at indicated time points to determine bacterial loads. Blood samples collected from the orbital sinus were used for the enzyme-linked immunosorbent assay (ELISA). The peritoneal cells were collected and incubated in complete Roswell Park Memorial Institute (RPMI) 1640 medium supplemented with 10% fetal calf serum (FCS) in cell culture plates for 2 h at 37°C. After removal of the floating cells, the attached M (Ͼ90% purity, as estimated by an F4/80 ϩ assay) were used for further analysis. Sections of paraffinembedded nasal mucosa were stained with hematoxylin and eosin (H&E) solution. Animal care and experiments were handled in accordance with the guidelines issued by the Swedish Ethical Committee on Animal Experiments.
Flow cytometry. Cells were stained with the indicated antibodies according to manufacturers' protocols and analyzed on a BD LSR Fortessa cell analyzer. The data were analyzed using the FlowJo software program (Tree Star, San Carlos, CA). The phenotype of the human cells was determined using antibodies detecting membrane CD14, CD1a, CD80, CD83, CD86, HLA-DR, CD206, or TLR4 conjugated with Horizon V450, FITC, phycoerythrin (PE), PE-Cy7, or allophycocyanin (APC) (BD Biosciences, Erembodegem, Belgium) and FITC-conjugated CD200R (AbD Serotec, Raleigh, NC). The mouse peritoneal cells were analyzed using antibodies to Ly6G, Ly6C, CD206, and CD11b (BD Pharmingen); F4/80 (AbD Serotec); and CD3, CD19, and CD205 (MyBioSource, San Diego, CA) conjugated with PE, FITC, APC, or APC-H7. Dead or apoptotic cells generated during detachment were excluded by dual staining with FITC-conjugated annexin V in each experiment.
Bacterial phagocytosis and intracellular killing. Cells were grown in six-well plates and infected with FITC-labeled FAM20 (multiplicity of infection [MOI] , 100) for 40 min at 37°C or 4°C to determine the number of total cell-associated bacteria or adherent bacteria, respectively. After washing, the cells were harvested and fixed with 4% paraformaldehyde, and FITC fluorescence was quantified via flow cytometric analysis. The number of intracellular bacteria was determined by subtracting the fluorescence of adherent bacteria from that of the total cell-associated bacteria.
The killing ability of cells was determined using a gentamicin protection assay. Briefly, cells were infected with FAM20 (MOI, 100) for 40 min, followed by incubation in gentamicin (200 g/ml) for 30 min. Cells were lysed with 1% saponin, and "total internalized bacteria" were quantified after plating appropriate dilutions of the lysates. Following gentamicin treatment, some cells were incubated with fresh medium for an additional 1 h, and the intracellular "surviving bacteria" were quantified as described above. The proportion of intracellular killed bacteria was calculated using the following formula: 100 ϫ (total internalized bacteria Ϫ surviving bacteria)/total internalized bacteria. All samples were tested in triplicate, and the experiments were repeated at least three times.
Measurement of cytokines and nitrite. Levels of human IL-6, IL-10, IL-12, and TNF-␣ were quantified using ELISA kits from BioLegend, Levels of mouse IL-6, TNF-␣, and IL-10 were determined using ELISA kits from BioSite (Täby, Sweden). Nitrite levels were measured using a Griess assay (Promega). All analyses were performed according to the manufacturer's instructions.
qRT-PCR. Total cellular RNA was isolated with an RNeasy minikit (Qiagen, Valencia, CA) and transcribed to cDNA using a RevertAid H Minus First-Strand cDNA synthesis kit (Fermentas, Glen Burnie, MD). Real-time reverse transcription-PCR (qRT-PCR) was performed on a LightCycler 480 real-time PCR system (Roche Diagnostics, Mannheim, Germany) using SYBR Green for real-time monitoring of the PCR. The primers used are listed in Table S1 in the supplemental material. The threshold cycle (C T ) values of the target genes were normalized to the C T value of the reference gene (mouse glyceraldehyde 3-phosphate dehydrogenase [GAPDH] or human ribosomal protein L37A [RPL37A]) and expressed as fold change compared with the control sample.
Immunoblotting. To quantify protein phosphorylation, the cell lysates were subjected to 10% sodium dodecyl sulfate (SDS)-PAGE, and immunoblotting was performed with mouse antibodies to ERK1/2 (pT202/pY204), JNK (pT183/pY185), and p38 (pT180/pY182) (MAPK activation sampler kit; BD Biosciences) or rabbit anti-phospho-Akt (Cell Signaling Technology, Danvers, MA). ␤-Actin was used as a control protein. Donkey anti-rabbit immunoglobulin G (IgG) or donkey anti-mouse IgG (1:15,000; Li-Cor Biosciences) labeled with IRDye 800CW or IRDye 680RD was used as the secondary antibody. Signals were detected using an Odyssey infrared imaging system (Li-Cor Biosciences), and densitometric analysis was performed using the ImageJ software program (http://imagej .nih.gov/ij).
Statistics. Differences between the groups were analyzed by analysis of variance (ANOVA) followed by the Bonferroni post hoc test. The MannWhitney U test was applied for the murine survival assay. The other animal experiments were analyzed by paired Student's t test. P values of less than 0.05 were considered statistically significant. Statistical analysis was performed using the Prism 5.0 software (GraphPad, La Jolla, CA).
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